CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...